Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition
55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000